Stock Events

Stock Events

Relmada Therapeutics (4E2.F) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.76

-0.65

-0.54

-0.43

Details

Expected EPS

-0.43255679999999996

Actual EPS

-0.5226727999999999

Surprise EPS

-0.09

Surprise Percent

+20.83%

Description

Relmada Therapeutics (4E2.F) has reported earnings of -0.5226727999999999 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.